StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > 45 min left

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Apr 01, 2021 12:20am

204 Views

Post# 32920628

RE:RE:RE:RE:45 min left

I think its past your bed time Liked2think. you know you get cranky when you don't get your sleep. You're a growing boy now, back to bed with you so you can grow up big and strong

Liked2Think wrote: im sure its all part of the master plan to wait until the day before a long weekend to release the news that we got a 2 billion dollar buy out and all our shares are now $44

technically another missed promise by Tripp. No Aristotle in Q1.

I fall for it every time.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China